EndoStim, Inc.: Series B $6M

Posted in I - Series B, Q - 3Q10, R - SOUTH WEST, X - Device (GI), X - Device (Neuromuscular), X- GERD, XX - AZ

EndoStim (Phoenix, AZ) a development-stage medical device company focused on gastrointestinal and neuromuscular disorders, closed a $6M Series B financing. Participants include Santé Ventures, Prolog Ventures, Vectis Healthcare & Life Sciences Fund.

Reata Pharmaceuticals, Inc.: Series D $78M

Posted in I - Series D, Q - 3Q10, R - SOUTH WEST, X - Inflammation, X - Renal, XX - TX

Reata Pharmaceuticals (Irving, TX) a clinical-stage small molecule company focused on inflammation modulation in chronic kidney disease, closed a $78M Series D financing. Participants include CPMG and Novo Ventures.

Ensysce Biosciences, Inc.: Series A $1.5M

Posted in I - Series A, Q - 2Q10, R - SOUTH WEST, X - Device (Delivery), XX - TX

Ensysce Biosciences (Houston, TX) a development-stage biopharma company focused on carbon nanotube complexes for chemotherapeutic transport, closed a $1.5M Series A financing. Participants include Texas Emerging Technology Fund.

Palmaz Scientific, Inc.: Series A $3M

Posted in I - Series A, Q - 2Q10, R - SOUTH WEST, X - Biomaterial, XX - TX

Palmaz Scientific (Dallas, TX) a development-stage nano-biomaterials company focused on a vapor deposition process to increase the reliability of implantable prosthetic devices, closed a $3M Series A financing. Participants include Texas Emerging Technology Fund.

TVA Medical, Inc.: Series A $2.6M

Posted in I - Series A, Q - 1Q10, R - SOUTH WEST, X - Device (Renal), XX - TX

TVA Medical (Austin, TX) a development-stage medical device company focused on a minimally invasive approach for the treatment of end-stage renal disease, closed a $2.6M Series A financing. Participants include Santé Ventures.

Savara Pharmaceuticals, Inc.: Series A $1.4M

Posted in I - Series A, Q - 4Q09, R - SOUTH WEST, X - Device (Delivery), XX - TX

Savara Pharmaceuticals (Austin, TX) a development-stage Dry powder and nebulizer-based drug delivery solution, closed a $1.4M Series A financing. Participants were not identified.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Ortho Kinematics, Inc.: Series A $2.0M

Posted in I - Series A, Q - 4Q09, R - SOUTH WEST, X - Device (Diagnostic), X - Device (Spine), XX - TX

Ortho Kinematics (Austin, TX) a development-stage spine diagnostics company focused on inter-vertebral motion analysis, closed a $2M Series A financing. Participants include PTV Sciences, Texas Emerging Technology Fund and Gatebridge Investments.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Terapio Corp.: Series A $5M

Posted in I - Series A, Q - 4Q09, R - SOUTH WEST, X - Radiodermatitis, X - THx Delivery

Terapio (Austin, TX) a preclinical-stage biopharmaceutical company focused on radiodermatitis, closed a $5M Series A financing. Participants have included Santé Ventures and Texas Emerging Technology Fund.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Bellicum Pharmaceuticals, Inc.: Series A $4.5M

Posted in I - Series A, Q - 4Q09, R - SOUTH WEST, X - Oncology, X - Vaccines

Bellicum Pharmaceuticals (Houston, TX) a clinical-stage biopharmaceutical company focused on immune-modulating therapeutic vaccines for prostate cancer, closed a $4.5M Series A financing. Particiapnts include the Texas Emerging Technology Fund.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb

Vidacare Corp.: Series D $7.6M

Posted in I - Series D, Q - 3Q09, R - SOUTH WEST, X - Device (Intraosseous), XX - TX

Vidacare (San Antonio, TX) a commercial-stage medical device company focused on enabling intraosseous access technologies, closed a $7.6M Series D financing. Participants include Piper Jaffray, Telegraph Hill Partners, Tullis Health Investors and Incyte Venture.

« Previous Entries

to top of page...